Amgen Inc (AMGN)
313.66
+0.84
(+0.27%)
USD |
NASDAQ |
May 10, 13:16
Amgen Price: 313.66 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 09, 2024 | 309.53 | 314.60 | 306.32 | 312.82 | 2.281M |
May 08, 2024 | 300.12 | 307.57 | 298.89 | 307.31 | 2.860M |
May 07, 2024 | 301.75 | 302.91 | 298.51 | 300.30 | 2.452M |
May 06, 2024 | 310.88 | 312.73 | 297.52 | 299.48 | 4.718M |
May 03, 2024 | 313.39 | 322.60 | 308.68 | 311.29 | 9.645M |
May 02, 2024 | 277.69 | 278.63 | 274.90 | 278.39 | 3.177M |
May 01, 2024 | 274.18 | 279.84 | 273.38 | 277.37 | 2.324M |
Apr 30, 2024 | 276.11 | 276.12 | 272.35 | 273.94 | 2.477M |
Apr 29, 2024 | 269.18 | 276.86 | 268.99 | 276.38 | 2.679M |
Apr 26, 2024 | 265.72 | 271.68 | 265.72 | 269.98 | 2.437M |
Apr 25, 2024 | 273.45 | 274.35 | 267.24 | 269.38 | 1.794M |
Apr 24, 2024 | 270.63 | 274.86 | 269.64 | 273.01 | 2.467M |
Apr 23, 2024 | 272.14 | 274.48 | 271.05 | 273.54 | 2.493M |
Apr 22, 2024 | 269.84 | 273.14 | 269.84 | 271.91 | 2.166M |
Apr 19, 2024 | 264.63 | 269.38 | 260.68 | 268.93 | 3.380M |
Apr 18, 2024 | 265.64 | 265.92 | 262.58 | 262.75 | 2.083M |
Apr 17, 2024 | 267.54 | 268.78 | 263.38 | 264.07 | 2.175M |
Apr 16, 2024 | 266.83 | 267.51 | 263.81 | 265.64 | 2.018M |
Apr 15, 2024 | 269.93 | 270.93 | 264.34 | 265.51 | 1.740M |
Apr 12, 2024 | 268.77 | 269.30 | 266.16 | 267.28 | 2.140M |
Apr 11, 2024 | 270.22 | 273.00 | 268.44 | 270.00 | 2.170M |
Apr 10, 2024 | 267.96 | 268.38 | 264.63 | 266.45 | 1.950M |
Apr 09, 2024 | 270.19 | 271.29 | 268.58 | 270.36 | 1.793M |
Apr 08, 2024 | 269.48 | 270.21 | 267.56 | 269.20 | 1.831M |
Apr 05, 2024 | 265.90 | 273.07 | 265.08 | 269.95 | 2.294M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
166.70
Minimum
May 31 2019
324.56
Maximum
Feb 01 2024
237.99
Average
237.21
Median
May 12 2020
Price Benchmarks
Gilead Sciences Inc | 66.07 |
Johnson & Johnson | 149.50 |
Eli Lilly and Co | 764.50 |
Merck & Co Inc | 130.50 |
Vertex Pharmaceuticals Inc | 420.06 |
Price Related Metrics
PE Ratio | 44.81 |
PS Ratio | 5.706 |
Price to Book Value | 33.50 |
Price to Free Cash Flow | 23.74 |
Earnings Yield | 2.23% |
Market Cap | 168.26B |
Operating PE Ratio | 24.19 |
Normalized PE Ratio | 44.81 |